Research Article

Diagnostic Accuracy of circRNAs in Esophageal Cancer: A Meta-Analysis

Table 2

Detailed information of overall meta-analysis and subgroup analyses.

AnalysisNo. of studiesSensitivity (95% CI)Specificity (95% CI)PLR (95% CI)NLR (95% CI)DOR (95% CI)TPFPFNTN

Overall50.79 (0.69-0.87)0.85 (0.68-0.94)5.27 (2.46-11.32)0.24 (0.16-0.36)21.66 (9.33-50.30)1543243146
Sample size
 ≥7020.78 (0.69-0.86)0.86 (0.78-0.92)5.29 (3.26-8.59)0.21 (0.05-0.93)30.04 (12.83-70.33)78142286
 <7030.78 (0.69-0.86)0.77 (0.66-0.68)5.00 (0.89-28.03)0.28 (0.19-0.42)16.59 (3.49-78.98)76182160
circRNA expression
 Upregulated20.78 (0.67-0.88)0.68 (0.54-0.80)2.94 (0.70-12.41)0.32 (0.19-0.52)9.19 (2.28-37.04)51171436
 Downregulated30.78 (0.70-0.85)0.88 (0.81-0.93)6.42 (3.28-12.59)0.23 (0.10-0.50)34.55 (15.65-76.27)1031529110

95% CI: 95% confidence interval; PLR: positive likelihood ratio; NLR: negative likelihood ratio; DOR: diagnostic odds ratio; TP: true positive; FP: false positive; FN: false negative; TN: true negative.